FR2100876A1 - - Google Patents

Info

Publication number
FR2100876A1
FR2100876A1 FR7124989A FR7124989A FR2100876A1 FR 2100876 A1 FR2100876 A1 FR 2100876A1 FR 7124989 A FR7124989 A FR 7124989A FR 7124989 A FR7124989 A FR 7124989A FR 2100876 A1 FR2100876 A1 FR 2100876A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7124989A
Other languages
French (fr)
Other versions
FR2100876B1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2100876A1 publication Critical patent/FR2100876A1/fr
Application granted granted Critical
Publication of FR2100876B1 publication Critical patent/FR2100876B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7124989A 1970-07-08 1971-07-08 Expired FR2100876B1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1030570 1970-07-08
CH1787870 1970-12-03

Publications (2)

Publication Number Publication Date
FR2100876A1 true FR2100876A1 (ja) 1972-03-24
FR2100876B1 FR2100876B1 (ja) 1974-11-15

Family

ID=25706322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7124989A Expired FR2100876B1 (ja) 1970-07-08 1971-07-08

Country Status (6)

Country Link
BE (1) BE769609A (ja)
DD (1) DD98095A5 (ja)
DE (1) DE2132883A1 (ja)
FR (1) FR2100876B1 (ja)
GB (1) GB1360860A (ja)
NL (1) NL7109409A (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2166356A1 (ja) * 1972-01-03 1973-08-17 Beecham Group Ltd
EP0061234A2 (en) * 1981-03-05 1982-09-29 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them
FR2509310A1 (fr) * 1980-09-25 1983-01-14 Toyama Chemical Co Ltd Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
FR2533216A1 (fr) * 1982-09-22 1984-03-23 Toyama Chemical Co Ltd Nouvelles cephalosporines, et leurs sels

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994876A (en) * 1975-07-22 1976-11-30 Richardson-Merrell Inc. 6-[α-AMINO-ω-(2,3-METHYLENEDIOXYPHENYL)ACYLAMIDO]PENICILLANIC ACID DERIVATIVES
US3994877A (en) * 1975-07-22 1976-11-30 Richardson-Merrell Inc. 6-[α-AMINO-ω-(3,4-METHYLENEDIOXYPHENYL)ACYLAMIDO]PENICILLANIC ACID DERIVATIVES

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1337775A (fr) * 1962-05-16 1963-09-20 Glaxo Lab Ltd Nouveaux dérivés de la céphalosporine c et leurs procédés de préparation
FR2001491A1 (ja) * 1968-02-07 1969-09-26 Lilly Co Eli
FR1589109A (ja) * 1967-08-21 1970-03-23

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1337775A (fr) * 1962-05-16 1963-09-20 Glaxo Lab Ltd Nouveaux dérivés de la céphalosporine c et leurs procédés de préparation
FR1589109A (ja) * 1967-08-21 1970-03-23
FR2001491A1 (ja) * 1968-02-07 1969-09-26 Lilly Co Eli

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2166356A1 (ja) * 1972-01-03 1973-08-17 Beecham Group Ltd
FR2509310A1 (fr) * 1980-09-25 1983-01-14 Toyama Chemical Co Ltd Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
FR2511377A1 (fr) * 1980-09-25 1983-02-18 Toyama Chemical Co Ltd Nouvelles cephalosporines, et leurs sels
EP0061234A2 (en) * 1981-03-05 1982-09-29 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them
EP0061234A3 (en) * 1981-03-05 1983-11-16 Beecham Group Plc Cephalosporin derivatives, process for their preparation and pharmaceutical preparations containing them
FR2533216A1 (fr) * 1982-09-22 1984-03-23 Toyama Chemical Co Ltd Nouvelles cephalosporines, et leurs sels

Also Published As

Publication number Publication date
NL7109409A (ja) 1972-01-11
DD98095A5 (ja) 1973-06-05
DE2132883A1 (de) 1972-01-13
GB1360860A (en) 1974-07-24
FR2100876B1 (ja) 1974-11-15
BE769609A (fr) 1972-01-07

Similar Documents

Publication Publication Date Title
AR204384A1 (ja)
FR2100876B1 (ja)
ATA96471A (ja)
AU1146470A (ja)
AU2044470A (ja)
AU2130570A (ja)
AU1833270A (ja)
AU2017870A (ja)
AU2085370A (ja)
AR195465A1 (ja)
AU1969370A (ja)
AU1881070A (ja)
AU1841070A (ja)
AU1083170A (ja)
AU1064870A (ja)
AU1872870A (ja)
AU1879170A (ja)
AU1235770A (ja)
AU1189670A (ja)
AU2144270A (ja)
AU2131570A (ja)
AU2130770A (ja)
AU1832970A (ja)
AU1004470A (ja)
AU2119370A (ja)

Legal Events

Date Code Title Description
ST Notification of lapse